Introduction
Genetic evidence from early onset cases of Alzheimer's disease indicates that metabolism of the β-amyloid peptide (Aβ) is clearly linked to the disease (1) . The β-amyloid cascade theory states that excessive deposition of Aβ in the brain is an important step in the pathogenesis of Alzheimer's disease (2) . While there is a poor correlation between the density of deposits and the severity of the disease, a correlation is found between the levels of soluble A β and synaptic damage and cognitive impairment (3) .
There have been many reports of synthetic Aβ being toxic to neuronal cells (4, 5) .
However the precise mechanism(s) of action and the nature of the toxic A β species remain to be identified (reviewed in (6) ).
AD is associated with extensive oxidative damage to brain tissue (7) (8) (9) (10) . The cause of the observed oxidative stress has been debated with a number of possible mechanisms postulated. These include deficits in calcium regulation, b rought about by either the formation in cell membranes of calcium channels (11) or modulation of an existing channel (12) . An alternative model proposes the direct production of reactive oxygen species (ROS) by Aβ (9, 13) . A common factor in most proposed mechanisms of Aβ toxicity is the oligomerization of Aβ, whether as dimers or trimers (14, 15) or larger aggregates such as protofibrils (16) or the megadalton fully formed amyloid fibril (17, 18) . (19) (20) (21) (22) . Both zinc and copper are released into the synaptic cleft (300 uM for Zn, 30 uM Cu), and markedly elevated levels of Cu (400 µM), Zn (1 mM) and Fe
(1 mM) are found in amyloid deposits in AD-affected brains (23, 24) . The oxidative stress observed in AD may be a consequence of the production of ROS by metal-bound forms of A β. The observation that senile plaques isolated from AD brains generated ROS in a manner dependent upon Cu and Fe (22, 25) supports this hypothesis.
The ability of A β to coordinate and reduce Cu in vitro must result in the peptide being oxidized. Indeed, mass spectrometry has shown that Cu complexes were able to oxygenate Aβ, with the most likely site of oxidation being the sulfur atom of Met35 (26) .
Aβ peptides with the sulfur of Met35 oxidized (hereafter referred to as Met(O)Aβ) have been isolated from AD amyloid brain deposits (27, 28) . In addition, Dong et al. (29) have recently shown in a Raman spectroscopic study of senile plaque cores isolated from diseased brains that much of the Aβ in these deposits contained methionine sulfoxide and that copper and zinc were coordinated to the histidine residues.
The importance of metal ions to the pathogenesis of AD is highlighted by our observation that the amount of A β ? deposition in a transgenic mouse expressing amyloidogenic human A β was substantially decreased by treating the mice with an orally available metal chelator (clioquinol) capable of crossing the blood-brain barrier (30) . The significance of this result has been further highlighted by the successful conclusion of a phase II clinical trial that showed that clioquinol inhibited cognitive decline in moderate to severe AD patients (31) . Recently, the importance of Zn 2+ i n plaque formation has been emphasized by the finding that age and female sex related plaque formation in by guest on November 19, 2017 http://www.jbc.org/ Downloaded from APP2576 transgenic mice was greatly reduced upon the genetic ablation of the zinc transporter 3 protein, which is required for zinc transport into synaptic vesicles (32).
An alternative, but not mutually exclusive, hypothesis to explain Aβ neurotoxicity is based on A β interacting with membranes and/or membrane proteins. Given that the Aβ peptide contains part of the putative transmembrane domain of the amyloid precursor protein (APP), it is not surprising that the peptide interacts with cell membranes and lipoproteins. Numerous reports have described the effects of Aβ on membranes and lipid systems and their possible roles in A β neurotoxicity (33) . Our previous studies (34, 35) indicated that the interaction between large unilamellar vesicles (LUVs) and Aβ in the presence of Cu and Zn resulted in α-helical oligomeric channel-like structures being formed.
Met35 has been reported to play a key role in the toxicity of Aβ since Aβ peptides with Met35 replaced by either norleucine or Cys are non-toxic and unable to induce oxidative stress responses in cells (36) . Aβ peptides with an oxidized m ethionine have also been reported to be non-toxic (37) . We have shown that when Met35 is either missing, as in A β1-28, or sequestered within a lipid environment and, therefore, not available as a co-factor, there is no metal reduction and hence no conditions for Fenton chemistry (34) . In addition to ameliorating the toxic behavior of A β, the oxidation of Met35 also alters the physical properties of the peptide. Met(O)Aβ is more soluble in aqueous solution and there is a disruption of the local helical structure when the peptide is dissolved in sodium dodecyl sulfate micelles (38) . 
Experimental Procedures

Materials and Methods
The acidic phospholipid spin label 16NPS was synthesized according to Hubbell and McConnell (41) . The water-soluble spin label TEMPO choline chloride was obtained from Molecular Probes Inc (Oregon). All spin probes were checked for purity and to ensure that their number of spins/M were > 90% of theory (42) .
Preparation of LUV.
Synthetic palmitoyl phosphatidyl choline (POPC) was purchased from Sigma, and palmitoyl phosphatidyl serine (POPS) was purchased from Avanti Polar Lipids Inc.
Large unilamelar vesicles (LUV) were prepared by dissolving equal quantities of POPS and POPC in chloroform, which was then evaporated off. The lipids were then dissolved in 10mM phosphate buffer pH 6.8. Some glass beads were added and the mixture was shaken for 1hr at 37°C. The solution was decanted from the glass beads and subjected to 5 freeze-thaw cycles in liquid nitrogen and a 37 o waterbath. The lipids were t hen extruded 11 times through a 0.2µm pore filter from Millipore, using an Avanti "miniextruder" apparatus. LUV were stored at 4°C and used within 48hrs of preparation as 
Synthesis of Met(O)Aβ42
Met(O)Aβ42 was synthesized as described above with the exception that 
Synthesis of Aβ39 with 13 C labels at C α of G9, 25, 33 and C ε of M35:
13 C Gly9, 25, 33, 13 C Met35-Aβ39 was synthesized on solid phase in an automated manner using a model 430A peptide synthesizer (Applied Biosystems Japan Inc) using a conventional t -Boc strategy and PAM resin. 13 C amino acids were loaded into the appropriate cartridges and the synthesis was performed using a method previously described (48) . days. Spectra were acquired on the precipitate that was collected by centrifugation, washed 3 times with MilliQ water and lyophilized overnight.
Solid-State NMR
Solid
EPR spectroscopy
Continuous-wave X -band EPR spectra were obtained using a Bruker ECS106 spectrometer equipped with a temperature controller and flow through cryostat. 
CD Spectroscopy
CD spectra of peptides in the LUV were obtained using a CD spectropolarimeter model 62DS (AVIV, Lakewood, New Jersey, U.S.A.). Peptide concentrations were determined using the molar extinction of the UV absorption from the tyrosine residue. The CD spectrum was obtained for each solution both neat and after a 1:4 dilution with MilliQ ® water. CD spectra were obtained using a 1 mm-path length quartz cell, acquired at 297 K in 0.5 nm steps over a 185 to 250 nm wavelength range.
Hydrogen Peroxide (H 2 O 2 ) Assay
H 2 O 2 production by A β peptides was measured using a fluorimetric assay. The mean and standard deviations of triplicate samples were calculated and compared.
Neuronal cell assay
Aβ42 and Met(O)Aβ42 peptide stocks were prepared by initially weighing out peptide and determining a theoretical 200 µM concentration by weight, dissolving the peptide in 20 mM NaOH, then rapidly diluting out in water and 10X PBS in a ratio of 2:7:1. All Aβ peptide solutions were sonicated in a water bath for 5 min, centrifuged for 5 min at high speed and the supernate used for the toxicity experiments. The final concentration of the peptides were further quantified according to procedures outlined by Huang et al (1997) .
Briefly, the absorbance value at OD 214 was measured using a UV spectrophotometer for the Aβ preparations and the protein concentration determined from BCA standard curves.
This method of A β preparation was found to be associated with increased solubility of the peptides. Clioquinol was purchased from Sigma.
Primary neuronal cultures
Cortical neuronal cultures were prepared as described previously 
Cell viability assays
Cell survival was monitored by phase contrast microscopy and cell viability quantitated using the MTS assay as described previously. Briefly, the medium was replaced with fresh Neurobasal medium supplemented with B27 lacking antioxidants and 25 µL MTS 
Results
Solid-State NMR confirms Aβ plus Cu 2+ oxidizes the sulfur of Met35
When Cu 2+ was added to Aβ essentially all the peptide precipitates and very little peptide remains in solution as has previously been reported (50, 51) . Subsequently, t o confirm that Met35 is being oxidized following Cu treatment a 13 C CP MAS spectrum of the unoxidized form of the Aβ39 peptide was obtained ( Fig. 1(a) ). 
Oxidation of the sulfur of Met35 alters Aβ lipid interactions
To determine if the interaction between A β and Cu in a lipid environment is altered by Met35 oxidation a series of EPR spectra of 16NPS in POPS/POPC LUV in pH /M (Fig. 2) . All the spectra were recorded at 300K. It can be seen that the unoxidized, Aβ42 in the presence of Cu 2+ gives the motionally-restricted lipid component (marked with an arrow in Fig. 2(a) ) which is characteristic of systems with a rigid peptide segment inserted into the bilayer. In contrast, the Met(O)Aβ does not give rise to this phenomena indicating that the peptide has not penetrated into the core of the lipid bilayer (Fig 2b) . However, most of the peptide (~90%) was still bound to the LUV as determined by density gradient centrifugation in Metrizamide T Tris buffer.
In Fig. 3 the Cu 2+ EPR spectra of the Cu CD spectroscopy was used to determine if the oxidized Met35 altered the secondary structure of the peptide in a lipid environment (Fig. 5) . The Met(O)Aβ in a LUV environment is random coil and there is no conformational change when Cu 2+ is added. This is consistent with the metal failing to promote peptide insertion into the membrane. In contrast, the unoxidized peptide showed a β-sheet structure on the surface that converted to an α-helical structure upon addition of Cu 2+ or Zn
2+
, as previously reported (34) .
Hydrogen Peroxide generation by Met(O)Aβ plus Cu
2+
The ability of A β peptides incubated with Cu 2+ to generate H 2 O 2 has been previously reported (20, 22, 54 production is inhibited.
Neuronal cell assay
The neurotoxicity of the Met(O)Aβ peptide was tested to determine if, like the unoxidised peptide, this peptide is toxic to neuronal cells. The results depicted in Fig. 7 show that Met(O)Aβ had a similar degree of toxicity on neuronal cultures to that of the unoxidised A β. production. In addition, the metal chelator clioquinol is able to attenuate the toxicity of both unoxidized A β and Met(O)Aβ. A result that highlights the importance metal ions play in the production of the H 2 O 2 , as has been previously observed (20, 22) .
To confirm that the oxidized methionine was not reduced by the culturing conditions, conditioned media was collected at the end of 4 days of treatment and subjected to immunoprecipitation and the eluted peptide analyzed by mass spectrometry.
The spectra showed that the peptide mass profile of Met(O)Aβ was unchanged following the treatment of the cells (data not shown).
Discussion
Oxidative damage has been identified as a possible cause of the neurodegeneration associated with Alzheimer's disease. Aβ can react with Cu 2+ to generate H 2 O 2 with a reduction of the metal to Cu + (19, 22) . Our solid-state NMR experiments ( Fig. 1) show that reduction of the metal is coupled with the oxidation of lipid bilayer, whereas the unoxidised peptide adopts a β-sheet structure in this environment (34, 35) . Moreover, the addition of Cu 2+ or Zn 2+ to A β will drive the insertion of the unoxidized peptide into the membrane as an oligomeric complex that adopts a channel-like α-helical structure in doing so. However, the addition of metal ions to Met(O)Aβ does not result in such a structural transition and α-helical channel-like structures are not observed (Fig. 2) . Significantly, the oxidation of the sulfur of Met35 does not change the metal binding properties of the peptide (Fig. 3) . T his is consistent with the structural transitions of A β being associated with the hydrophobic C-terminus that also promotes higher-order oligomerisation. The inhibition of β-sheet formation on the surface of the LUV following oxidation of Met35 suggests that these β-sheet structures are the result of sequestering the Met residue into a hydrophobic environment.
Met(O), with a more hydrophilic character is not suited to this hydrophobic environment and the formation of higher-order β-sheet oligomers is inhibited. Similarly, oxidation inhibits the metal-mediated transition of A β to α-helical oligomeric channel-like structures despite not changing the metal binding site (Fig. 5) . This is probably due to the more hydrophilic sulfoxide interfering with the hydrophobic interactions at either the peptide/peptide interface or at the interface between the peptide and the hydrocarbon lipid chains at the core of the lipid bilayer.
A critical role for Met35 in the pathogenic activity of Aβ has been suggested with this residue being reported to be necessary for promoting neurotoxicity, aggregation and the generation of ROS (36, 37, 56, 57) . However, given that metal binding occurs near the N-terminus of Aβ, one would not expect oxidation of Met35 to have a large effect on the metal binding ability. This is supported by the recent results of Dong et al. (29) who used Raman spectroscopy to show the presence of Cu bound to the histidine residues of Met(O)Aβ in diseased human tissue. This was confirmed by our EPR spectra (Fig. 3) showing that the coordination sphere about the Cu was unaffected by Met(O). When Aβ binds Cu 2+ and reduces it to Cu + , Met35 is oxidized to the sulfoxide (Fig. 1) , so it was surprising that t here was still significant reduction of the Cu, albeit slower, when Cu It has been previously reported (19) (Fig. 7) . Importantly, Cu bound Met(O)Aβ exists in AD brains (29) .
The ability of clioquinol to inhibit the toxicity of both Aβ and Met(O)Aβ is highly significant in the light of recent findings showing that clioquinol is capable of markedly inhibiting Aβ ? deposition in a transgenic mouse expressing amyloidogenic human A β with a corresponding increase in general health and body weight parameters (30) .
Furthermore, in a small phase II human clinical trial clioquinol was able to inhibit cognitive decline in moderate to severe AD patients (31) .
It has previously been reported that Met(O)Aβ is non-toxic to cells after 24 hrs (37) . In contrast we show that a longer incubation period of 96 hrs results in a significant level of toxicity similar to unoxidised A β. Likewise, it was reported that Met(O)Aβ was unable to reduce Cu 2+ to Cu + but again the assay only had a one hour incubation period (37) . We found that at one hour < 10% of the available Cu 2+ was reduced in agreement with these findings. However our data (Fig. 4) 
